Perspective Therapeutics Files 8-K on Shareholder Vote Matters
Ticker: CATX · Form: 8-K · Filed: May 28, 2025 · CIK: 728387
Sentiment: neutral
Topics: corporate-governance, shareholder-meeting
TL;DR
Perspective Therapeutics had a shareholder vote on 5/28. Details TBD.
AI Summary
Perspective Therapeutics, Inc. filed an 8-K on May 28, 2025, to report on matters submitted to a vote of its security holders. The filing does not contain details about the specific proposals voted upon or their outcomes.
Why It Matters
This filing indicates that the company held a shareholder vote, which could pertain to significant corporate actions like board elections, mergers, or stock issuances.
Risk Assessment
Risk Level: low — The filing is procedural and does not disclose any new financial information or significant operational changes.
Key Numbers
- 001-33407 — Commission File Number (Identifier for the company's SEC filings)
- 41-1458152 — IRS Employer Identification No. (Company's tax identification number)
Key Players & Entities
- Perspective Therapeutics, Inc. (company) — Registrant
- May 28, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 2401 Elliott Avenue Suite 320 (address) — Principal Executive Offices
- Seattle, Washington (location) — Principal Executive Offices City and State
FAQ
What specific matters were submitted to a vote of Perspective Therapeutics' security holders on May 28, 2025?
The filing does not specify the exact matters voted upon, only that "Submission of Matters to a Vote of Security Holders" is the item being reported.
What was the outcome of the shareholder vote reported in this 8-K?
The filing does not disclose the results or outcomes of the shareholder vote.
Is there any financial information or guidance provided in this 8-K filing?
No, this 8-K filing is solely for reporting the submission of matters to a vote of security holders and does not contain financial information.
When was Perspective Therapeutics, Inc. incorporated?
Perspective Therapeutics, Inc. was incorporated in Delaware, as indicated by the filing.
What is the principal executive office address for Perspective Therapeutics, Inc.?
The principal executive offices are located at 2401 Elliott Avenue, Suite 320, Seattle, Washington 98121.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 28, 2025 regarding Perspective Therapeutics, Inc. (CATX).